DALIAN, China, Nov. 12 /Xinhua-PRNewswire-FirstCall/ -- China Bio-Immunity Corporation (China Bio-Immunity” or “the Company”), today announced that it plans to release third quarter 2008 financial results on November 14, 2008, and will hold a conference call to discuss the results on November 17, 2008, the following business day.
Details of the call:
The Company will hold a conference call at 9:00 AM ET on November 17, 2008 to discuss its fiscal third quarter 2008 results. Listeners may access the call by dialing 1-888-264-8952 or 1-913-312-1492 for international callers, access code: 9830874. A webcast will also be available through the Company website at http://www.jgad-bio.com . A replay of the call will be available through December 1, 2008. Listeners may access the replay by dialing 1-888- 203-1112 or 1-719-457-0820 for international callers, access code: 9830874.
About China Bio-Immunity
Based in Dalian, China, China Bio-Immunity develops, produces, manufactures and markets internally developed vaccine-based prophylactics and therapeutics. The Company has sales and marketing efforts in the 24 main provinces and major cities in the People’s Republic of China (“P.R.C.”). Its principal products, its Rabies Vaccine and Mumps Vaccine, are sold and distributed by a network of wholesale distributors, as well as through retail customers. In addition to the current distribution structure, the Company plans to further market its products through distribution agreements with local agents in several developing countries, including, but not limited to India, South Africa, and countries throughout Southeast Asia. To learn more about the Company, visit http://www.jgad-bio.com .
CONTACT: Ashley M. Ammon and Christine Duan of Integrated Corporate
Relations, Inc., +1-203-682-8200 (Investor Relations), both for China Bio-
Immunity Corporation
Web site: http://www.jgad-bio.com/
